Subtype
Colorectal Neoplasm
CI-CAN-00002404Explore in graph →
Non-malignant1,783 active trials21 approved drugs382 evidence items
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00002404Explore in graph →
Clinical trials
8,601 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06363123 | Plasma Metabolic Biomarkers for Multi-Cancer Diagnosis | unknown | — | 2,700 | Beijing Friendship HospitalOTHER | 1 | Apr 15, 2024 | clinicaltrials |
| NCT06014372 | Envafolimab Monotherapy or Envafolimab + CAPEOX as Neoadjuvant Therapy for Locally Advanced Colorectal Cancer | unknown | Phase 2 | 55 | Sun Yat-sen UniversityOTHER | 1 | Apr 12, 2024 | clinicaltrials |
| NCT06362902 | Laparoscopic Right Hemicolectomy With Transrectal Specimen Extraction for Colon Cancer | unknown | N/A | 37 | National Cancer Center, ChinaOTHER | 1 | Apr 12, 2024 | clinicaltrials |
| NCT06363552 | A Study of SC-0191 in Subjects With Metastatic Colorectal Cancer | unknown | Phase 2 | 36 | Tianshu LiuOTHER | 1 | Apr 12, 2024 | clinicaltrials |
| NCT06139926 | Clinical Study of Dexmedetomidine Administered Intranasally to Relieve Perioperative Anxiety and Depression in Patients With Colorectal Tumors | unknown | Phase 3 | 126 | First Affiliated Hospital of Chongqing Medical UniversityOTHER | 1 | Apr 9, 2024 | clinicaltrials |
| NCT06354595 | Feasibility Study of Multidimensional Rehabilitation in the Metaverse | unknown | N/A | 10 | Qu ShenOTHER | 1 | Apr 9, 2024 | clinicaltrials |
| NCT06351384 | Early Detection and Risk Stratification of Colorectal Cancer Based on miRNA Platform | unknown | — | 600 | Sir Run Run Shaw HospitalOTHER | 0 | Apr 8, 2024 | clinicaltrials |
| NCT06347198 | Oral Inulin in Combination With Fruquintinib Plus Sintilimab as Third- or Further-line Treatment in Metastatic Colorectal Cancer | unknown | Early Phase 1 | 30 | Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyOTHER | 1 | Apr 4, 2024 | clinicaltrials |
| NCT06341322 | Using Behavioural and Cultural Insights to Increase Colorectal Cancer Home-testing in Croatia | unknown | N/A | 13,000 | Veerle SnijdersOTHER | 1 | Apr 2, 2024 | clinicaltrials |
| NCT05311618 | Study of NGM438 as Monotherapy and in Combination With Pembrolizumab in Advanced or Metastatic Solid Tumors | unknown | Phase 1 | 71 | NGM Biopharmaceuticals, IncINDUSTRY | 1 | Apr 1, 2024 | clinicaltrials |
| NCT05526846 | Introducing a Plant-Based Diet for Patients With Colorectal Diseases | unknown | N/A | 60 | Stanford UniversityOTHER | 1 | Mar 28, 2024 | clinicaltrials |
| NCT06335147 | PD1 Antibody Combined With mFOLFOX6 Neoadjuvant Therapy for Advanced Resectable Metastatic Colon Cancer | unknown | N/A | 23 | Henan Cancer HospitalOTHER_GOV | 0 | Mar 28, 2024 | clinicaltrials |
| NCT04543695 | A Study of Total Neoadjuvant Therapy for High-risk Locally Advanced Rectal Cancer | unknown | Phase 2 | 255 | Cancer Institute and Hospital, Chinese Academy of Medical SciencesOTHER | 1 | Mar 26, 2024 | clinicaltrials |
| NCT05305820 | Perioperative Exercise and Nutritional Optimisation Prehabilitation Before Surgery for Patients With Peritoneal Malignancy(PANO) | unknown | N/A | 36 | Dublin City UniversityOTHER | 1 | Mar 21, 2024 | clinicaltrials |
| NCT06322563 | Combination of LTC004 and Regorafenib to Treat Patients With Advanced/Metastatic CRC | unknown | Phase 2 | 20 | Tianjin Medical University Cancer Institute and HospitalOTHER | 1 | Mar 21, 2024 | clinicaltrials |
| NCT06008522 | Safety and Feasibility of Immuno-OCT(DETOUR) | unknown | N/A | 15 | University Medical Center GroningenOTHER | 0 | Mar 20, 2024 | clinicaltrials |
| NCT06319404 | Immune Function of Colorectal Cancer Lymph Nodes | unknown | — | 500 | Shanxi Province Cancer HospitalOTHER | 0 | Mar 20, 2024 | clinicaltrials |
| NCT06321640 | Study for the Multidimensional Analyses of Resistance and Toxicity to Immune- and Targeted-therapies.(POSITive) | unknown | — | 265 | European Institute of OncologyOTHER | 1 | Mar 20, 2024 | clinicaltrials |
| NCT06322147 | Chemotherapy With Cetuximab as Conversion Therapy in RAS/BRAF WT Unresectable Liver Metastasis Right-sided Colon Cancer | unknown | — | 50 | Qilu Hospital of Shandong UniversityOTHER | 1 | Mar 20, 2024 | clinicaltrials |
| NCT06225622 | Dose Escalation and Expansion Clinical Trial of Irinotecan Liposome Combined With Oxaliplatin and 5-FU/LV Plus Bevacizumab as First-line Treatment of Metastatic Colorectal Cancer | unknown | Phase 1 | 78 | Shanghai Zhongshan HospitalOTHER | 1 | Mar 19, 2024 | clinicaltrials |
| NCT06304987 | Neoadjuvant Chemoradiotherapy Combined With PD-1 Inhibitor and PCSK9 Inhibitor for pMMR/MSS Locally Advanced Mid-low Rectal Cancer | unknown | Phase 2 | 50 | Beijing Friendship HospitalOTHER | 1 | Mar 19, 2024 | clinicaltrials |
| NCT06318234 | PET/MR Evaluation of Regression Grading After Neoadjuvant Therapy for Rectal Cancer | unknown | — | 32 | Xiao ChenOTHER | 1 | Mar 19, 2024 | clinicaltrials |
| NCT06302751 | A Mobile Application to Improve Postoperative Outcomes in Colorectal Cancer(RAISe-Care) | unknown | N/A | 600 | Istituto Clinico HumanitasOTHER | 1 | Mar 15, 2024 | clinicaltrials |
| NCT06311279 | End to End Versus Side to End Anastomosis After Anterior Resection of Cancer Rectum | unknown | N/A | 20 | Sohag UniversityOTHER | 1 | Mar 15, 2024 | clinicaltrials |
| NCT03951337 | 64Cu-ATSM PET/CT in Rectum Cancer (TEP 64Cu-ATSM-Rectum) | unknown | Phase 2 | 70 | Institut Cancerologie de l'OuestOTHER | 1 | Mar 12, 2024 | clinicaltrials |
| NCT05872867 | Study of WM-A1-3389 in Participants With Advanced or Metastatic Solid Tumors and Non-Small Cell Lung Cancer (MK-3475-E90/KEYNOTE-E90) | unknown | Phase 1 | 54 | Wellmarker BioINDUSTRY | 1 | Mar 12, 2024 | clinicaltrials |
| NCT06304597 | Evaluating PD-1/PD-L1 in Locally Advanced Rectal Cancer by Quantitative Fluorescence Molecular Endoscopy(PREDICT) | unknown | Phase 1 | 18 | University Medical Center GroningenOTHER | 1 | Mar 12, 2024 | clinicaltrials |
| NCT06300489 | Genotype-driven Weekly Irinotecan Liposomes in Combination With Capecitabine-based Neoadjuvant Chemoradiation for Locally Advanced Rectal Cancer | unknown | Phase 1 | 30 | Zhejiang Cancer HospitalOTHER | 1 | Mar 8, 2024 | clinicaltrials |
| NCT03936530 | Infrapyloric and Greater Curvature Lymph Node Metastasis in Colon Cancer | unknown | — | 432 | Shanghai Minimally Invasive Surgery CenterOTHER | 1 | Mar 7, 2024 | clinicaltrials |
| NCT05022030 | First-line mCapOX+Cetuximab vs. mFOLFOX6+Cetuximab for Metastatic Left-sided CRC With Wild-type RAS/BRAF Genes(CAPCET) | unknown | Phase 2 | 150 | West China HospitalOTHER | 1 | Mar 7, 2024 | clinicaltrials |
| NCT05111860 | Neoadjuvant Bevacizumab + Chemotherapy Combined With Short-course Radiotherapy | unknown | Phase 1 / Phase 2 | 20 | Shanghai Minimally Invasive Surgery CenterOTHER | 1 | Mar 7, 2024 | clinicaltrials |
| NCT02526264 | Evaluation of Quality of Life and Period of Hospitalization by Education(STELLA) | unknown | N/A | 138 | Krankenhaus NordwestOTHER | 1 | Mar 6, 2024 | clinicaltrials |
| NCT05870332 | Nationwide Study of Artificial Intelligence in Adenoma Detection for Colonoscopy(NAIAD) | unknown | — | 4,000 | King's College Hospital NHS TrustOTHER | 1 | Mar 6, 2024 | clinicaltrials |
| NCT06294873 | Stool Sample Collection Study | unknown | — | 40 | Innovis LLCINDUSTRY | 1 | Mar 6, 2024 | clinicaltrials |
| NCT02102789 | A Study of Systemic Chemotherapy With/Without HAI in Patients With Initially Unresectable Colorectal Liver Metastasis | unknown | Phase 3 | 142 | Yuhong LiOTHER | 1 | Mar 4, 2024 | clinicaltrials |
| NCT04780217 | Intravenous T3011 Given as a Single Agent and in Combination With Other Therapy in Subjects With Advanced Solid Tumors | unknown | Phase 1 / Phase 2 | 42 | ImmVira Pharma Co. LtdINDUSTRY | 1 | Mar 4, 2024 | clinicaltrials |
| NCT04653181 | Preoperative i.v. Iron Substitution in Patients With Colon Cancer(PREFECO) | unknown | N/A | 514 | Helsinki University Central HospitalOTHER | 1 | Feb 29, 2024 | clinicaltrials |
| NCT06165328 | The Comparison Between Computed Tomography and Colonoscope in Detecting Colorectal Tumors in Patients With FIT+(CTOCOCREC) | unknown | — | 241 | Hat Yai Medical Education CenterOTHER | 1 | Feb 29, 2024 | clinicaltrials |
| NCT06280690 | SGM-101 Tumor Targeted Fluorescence Endoscopy in Rectal Polyps With Suspected T1 Adenocarcinoma or High Grade Dysplasia(SGM-T1) | unknown | Phase 2 | 20 | Leiden University Medical CenterOTHER | 1 | Feb 29, 2024 | clinicaltrials |
| NCT06283303 | A Clinical Study of T3011 in Combination With Toripalimab and Regorafenib in Patients With Colorectal Cancer | unknown | Phase 1 | 8 | China Medical University, ChinaOTHER | 0 | Feb 29, 2024 | clinicaltrials |
| NCT06250166 | Feasibility, Acceptability, and Effectiveness of an Individualized Plant-based (iPLANT) Diet Plan in Colorectal Cancer: Mixed Method Embedded Design | unknown | N/A | 92 | National Cancer Institute, MalaysiaOTHER_GOV | 1 | Feb 28, 2024 | clinicaltrials |
| NCT04923620 | Neoadjuvant Cetuximab + Chemotherapy Combined With Short-course Radiotherapy | unknown | — | 51 | Shanghai Minimally Invasive Surgery CenterOTHER | 1 | Feb 26, 2024 | clinicaltrials |
| NCT06075849 | Phase I Study to Evaluate Safety and Anti-tumor Activity of PB101, an Anti-angiogenic Immunomodulating Agent | unknown | Phase 1 | 30 | Panolos BioscienceINDUSTRY | 1 | Feb 23, 2024 | clinicaltrials |
| NCT05279287 | Video Analysis of Errors and Technical Performance Within Minimally Invasive Surgery Short Title: Video Analysis in Minimally Invasive Surgery (VAMIS)(VAMIS) | unknown | — | 100 | The Griffin InstituteOTHER | 1 | Feb 22, 2024 | clinicaltrials |
| NCT04096417 | Pemigatinib for the Treatment of Metastatic or Unresectable Colorectal Cancer Harboring FGFR Alterations | unknown | Phase 2 | 14 | Academic and Community Cancer Research UnitedOTHER | 1 | Feb 21, 2024 | clinicaltrials |
| NCT04633512 | Safety and Feasibility of ActivSightTM in Human | unknown | N/A | 67 | Activ SurgicalINDUSTRY | 1 | Feb 21, 2024 | clinicaltrials |
| NCT06269445 | The Efficacy and Safety of Lcaritin Combined With Bevacizumab and FOLFIRI in Treatment of Liver Metastases From Colorectal Cancer | unknown | Phase 4 | 20 | Sir Run Run Shaw HospitalOTHER | 1 | Feb 21, 2024 | clinicaltrials |
| NCT06203587 | Clinical Study of GPA33-specific PET/CT for the Diagnosis of Colorectal Cancer | unknown | N/A | 40 | Huashan HospitalOTHER | 1 | Feb 20, 2024 | clinicaltrials |
| NCT03924466 | Repeatability of 68-GaNOTA-Anti-HER2 VHH1 PET/CT in Breast Carcinoma Patients(VUBAR) | unknown | Phase 2 | 55 | Universitair Ziekenhuis BrusselOTHER | 1 | Feb 16, 2024 | clinicaltrials |
| NCT06262581 | Neoadjuvant Tisleizumab(BGB-A317) for dMMR/MSI-H Non-late Stage CRC Patients Before Surgery | unknown | Phase 2 | 40 | Sun Yat-sen UniversityOTHER | 1 | Feb 16, 2024 | clinicaltrials |
Data updated 23 days agoSource updated Apr 15, 2024source: clinicaltrials